[
    "{\"step_by_step_thinking\": \"The patient's presentation of fatigue, dyspnea, and splenomegaly, along with the laboratory findings of anemia, leukopenia, thrombocytopenia, and small lymphocytes with cell membrane projections on peripheral blood smear, are suggestive of a lymphoproliferative disorder. The positive CD25 on cell immunophenotyping is a marker often associated with hairy cell leukemia. Cladribine and fludarabine are both used in the treatment of hairy cell leukemia. However, cladribine is often the first-line treatment due to its effectiveness and less severe side effects.\", \"answer_choice\": \"A\"}"
]